Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSRP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | EXOSC7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CASP9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZBTB39 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ADAMTSL5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | AL022397.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PRPF39 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | COA6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PCDHA5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | CTXN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |